Madhu Kumar

Work

Analyst Madhu Kumar works at GOLDMAN SACHS and is focused on the Healthcare sector with 390 price targets and ratings documented since 2016 spanning on 34 stocks. Previously, Madhu Kumar worked at B. RILEY, CHARDAN CAPITAL. Analyst's average stock valuation to be materialised ratio is 51.32% with an average time for price targets to be met of 115.79 days.

Most recent stock forecast was given on RETA, Reata Pharmaceuticals, Inc at 28-Nov-2022.

Madhu Kumar best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS INC).
The best stock recommendation documented was for CERE (CEREVEL THERAPEUTICS HOLDINGS INC) at 2/16/2022. The price target of $27 was fulfilled within 1 day with a profit of $2.24 (7.66%) receiving and performance score of 76.61.

Average potential price target upside

ABUS ALNY APLS ARCT ARWR CLVS DRNA EDIT IOVA MGTA NTLA RGLS SNDX APRE CLLS KRYS PASG GRTS VIR ACHN ALEC ARVN AVEO CERE DVAX EWTX FIXX MGEN RETA APLT HZNP JAZZ SBPH TCDA
ABUS ALNY APLS ARCT ARWR CLVS DRNA EDIT IOVA MGTA NTLA RGLS SNDX APRE CLLS KRYS PASG GRTS VIR ACHN ALEC ARVN AVEO CERE DVAX EWTX FIXX MGEN RETA APLT HZNP JAZZ SBPH TCDA